RE:RE:Perplexity Ai: The conclusion...Stinzo wrote: The conclusion is that the stock price sank, meaning the market or people do not believe in this macimorelin making any money. Ask your AI why no one is buying shares if the conclusion is so compelling.
CSCI still hasn't released a new post-merger plan for the company with the Q2 financials press release saying a "fulsome" update is coming "shortly". There is no plan prioritizing certain assets released to the public yet. We don't know when the company will run out of money and have to finance and what material valuation catalysts will be reached with current funding. There has never been any preclinical or clinical data released for the avenanthramide pill. PGX only works at the 10L pilot scale with the 5X and 10X scale-up to come. They are reviewing data for other programs and have had regulatory meetings scheduled to define a path forward. There is no path forward as the company appears to be rapidly burning money. There is no analyst coverage.
This company is still a mystery burning money. Half the company was trading on the TSX-V and Americans likely have little to no understanding. The stock is owned by retail with little inclination to understand the assets.
That diagnostic trial was to be the basis for a licensing deal with a significant upfront payment, in my opinion, and that was to finance the path forward. Unfortunately the path forward is clouded now and they are going to have to adjust their plan.
I believe the "fulsome" update that is expected is to be the launch of the new company on NASDAQ.